These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Medium-term outcome of tacrolimus immunosuppression following rejection or graft dysfunction in heart transplant patients. Marcus N; Khaghani A; Burke M; Yacoub M; Banner N Transplant Proc; 1998 Jun; 30(4):1134-5. PubMed ID: 9636460 [No Abstract] [Full Text] [Related]
4. Long-term outcome with the use of OKT3 induction therapy in heart transplant patients: a single-center experience. Adamson R; Obispo E; Dychter S; Dembitsky W; Moreno-Cabral R; Jaski B; Gordon J; Hoagland P; Moore K; King J; Andrews J; Rich M; Daily PO Transplant Proc; 1998 Jun; 30(4):1107-9. PubMed ID: 9636449 [No Abstract] [Full Text] [Related]
5. Excellent long-term survival of low-risk, first renal allografts using cyclosporine/azathioprine double therapy. Faull RJ; Bannister KM; Russ GR; Mathew TH; Clarkson AR Transplant Proc; 1999; 31(1-2):1155-6. PubMed ID: 10083516 [No Abstract] [Full Text] [Related]
6. Impact of cyclosporine dose on long-term outcome after heart transplantation. Valantine H; Hunt S; Gamberg P; Miller J; Luikart H Transplant Proc; 1994 Oct; 26(5):2710-2. PubMed ID: 7940848 [No Abstract] [Full Text] [Related]
7. Relative clinical impact of cyclosporine vs steroid induction therapy on renal function and allograft rejection in heart transplant recipients. Hanrahan JS; Ibrahim H; Tolman D; Kirchberg D; Salter D; Guerraty A; Mohanty PK Transplant Proc; 1996 Aug; 28(4):2107-8. PubMed ID: 8769168 [No Abstract] [Full Text] [Related]
8. Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation. Bruce DS; Newell KA; Woodle ES; Millis JM; Piper JB; Huss E; Thistlethwaite JR Transplant Proc; 1996 Aug; 28(4):2136-7. PubMed ID: 8769180 [No Abstract] [Full Text] [Related]
9. Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group. Jensik SC Transplant Proc; 1998 Jun; 30(4):1216-8. PubMed ID: 9636494 [No Abstract] [Full Text] [Related]
10. Antilymphocyte-antibody prophylaxis: review of the adult experience in heart transplantation. Taylor DO; Kfoury AG; Pisani B; Hammond EH; Renlund DG Transplant Proc; 1997 Dec; 29(8A):13S-15S. PubMed ID: 9414668 [No Abstract] [Full Text] [Related]
11. Mycophenolate mofetil versus azathioprine in simultaneous pancreas-kidney transplant recipients on cyclosporine. Fabrega AJ; Corwin CL; Hunsicker L Transplant Proc; 1998 Jun; 30(4):1562-3. PubMed ID: 9636634 [No Abstract] [Full Text] [Related]
15. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience. Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494 [No Abstract] [Full Text] [Related]